Clinical Trial Update: A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0002013) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating autologous dermal and epidermal cell injections for hair loss has completed. The study, sponsored by Aderans Research Institut…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Androgenetic Alopecia

Drugs mentioned

• Autologous dermal and epidermal cell injections

Snippet

Sponsor: Aderans Research Institute | Conditions: Androgenetic Alopecia, Male Pattern Baldness | Phase 2 | Status: COMPLETED